Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

MedCap

406

 

SEK

 

-2.64 %

Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview
Ownership
Investor consensus

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2001 and is headquartered in Stockholm.

Read more
Market cap
6.11B SEK
Turnover
3.66M SEK
Revenue
1.81B
EBIT %
15.07 %
P/E
29
Dividend yield-%
-
Financial calendar
23/7
2025

Interim report Q2'25

24/10
2025

Interim report Q3'25

6/2
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Regulatory press release5/30/2025, 6:30 AM

Ändring av antal aktier och röster i MedCap AB

MedCap
Regulatory press release5/27/2025, 4:30 PM

MedCap AB: Återköp av aktier i MedCap 22 maj 2025 - 27 maj 2025 - återköpsprogram avslutat

MedCap
Regulatory press release5/21/2025, 5:00 PM

MedCap AB: Återköp av aktier i MedCap 15 maj 2025 - 21 maj 2025

MedCap

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/14/2025, 4:45 PM

MedCap AB: Återköp av aktier i MedCap 8 maj 2025 - 14 maj 2025

MedCap
Regulatory press release5/7/2025, 3:30 PM

MedCap AB: MedCap beslutar om aktieåterköpsprogram

MedCap
Regulatory press release5/5/2025, 4:00 PM

MedCap AB: Stämmokommuniké årsstämma 5 maj 2025

MedCap
Press release4/30/2025, 5:47 AM

Redeye: MedCap Q1 2025 - Step by step

MedCap
Regulatory press release4/29/2025, 4:30 AM

MedCap AB: 7% tillväxt och EBITA marginalen återställd till 17%

MedCap
Regulatory press release4/29/2025, 4:30 AM

MedCap AB: 7% growth and EBITA margin recovers to 17%

MedCap
Regulatory press release4/2/2025, 12:30 PM

MedCap AB: KALLELSE ÅRSSTÄMMA I MEDCAP AB (PUBL) DEN 5 MAJ 2025

MedCap
Regulatory press release3/31/2025, 6:30 AM

Ändring av antal aktier och röster i MedCap AB

MedCap
Regulatory press release3/27/2025, 7:30 AM

MedCap AB: MedCap publicerar årsredovisning för 2024

MedCap
Regulatory press release2/6/2025, 12:58 PM

Finansinspektionen: Korrigering flaggningsmeddelande i MedCap AB (publ)

MedCap
Regulatory press release2/6/2025, 9:45 AM

Finansinspektionen: Flaggningsmeddelande i MedCap AB (publ)

MedCap
Press release2/3/2025, 7:53 AM

Redeye: MedCap Q4 2024 - A tale of euphoria and despair

MedCap
Regulatory press release1/31/2025, 5:30 AM

MedCap AB: MedCaps Affärsområde Hjälpmedel förvärvar Danrehab

MedCap
Regulatory press release1/31/2025, 5:30 AM

MedCap AB: God efterfrågan men otillfredsställande resultat. Starkt kassaflöde.

MedCap
Regulatory press release1/31/2025, 5:30 AM

MedCap AB: Good demand but unsatisfactory earnings. Strong cash flow.

MedCap
Regulatory press release1/31/2025, 5:30 AM

MedCap AB: MedCap's Business Area Assistive Tech Acquires Danrehab

MedCap
Regulatory press release1/16/2025, 5:30 PM

MedCap AB: Preliminärt resultat för fjärde kvartalet

MedCap
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team